Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 3,586,000 | 4,792,000 | 3,420,000 | 3,351,000 | 3,684,000 |
| Income taxes - deferred | -802,000 | -970,000 | -578,000 | -356,000 | -214,000 |
| Accounts receivable | -28,000 | -397,000 | -777,000 | 185,000 | -134,000 |
| Accounts payable and accrued liabilities | 789,000 | 402,000 | 452,000 | 451,000 | 86,000 |
| Other Working Capital | -615,000 | 764,000 | -707,000 | 1,409,000 | -325,000 |
| Other Operating Activity | 6,151,000 | 5,667,000 | 8,716,000 | 5,482,000 | 4,352,000 |
| Operating Cash Flow | $9,081,000 | $10,258,000 | $10,526,000 | $10,522,000 | $7,449,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,734,000 | -2,009,000 | -713,000 | -1,325,000 | -1,196,000 |
| Net Acquisitions | -2,524,000 | -3,828,000 | -858,000 | -5,594,000 | 5,034,000 |
| Purchase Of Investment | N/A | -134,000 | -488,000 | -311,000 | -137,000 |
| Other Investing Activity | -149,000 | -229,000 | -16,000 | -68,000 | -113,000 |
| Investing Cash Flow | $-4,407,000 | $-6,200,000 | $-2,075,000 | $-7,298,000 | $3,588,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 59,000 | 765,000 | 215,000 | -414,000 | 282,000 |
| Debt Issued | 0 | 48,000 | 1,549,000 | 0 | 2,019,000 |
| Debt Repayment | -953,000 | -3,949,000 | -3,009,000 | -2,390,000 | -4,186,000 |
| Common Stock Issued | 187,000 | 195,000 | 188,000 | 186,000 | 203,000 |
| Common Stock Repurchased | -302,000 | -593,000 | -497,000 | -382,000 | -822,000 |
| Dividend Paid | -4,704,000 | -4,454,000 | -4,168,000 | -4,008,000 | -3,937,000 |
| Other Financing Activity | -50,000 | -64,000 | -99,000 | -48,000 | -44,000 |
| Financing Cash Flow | $-5,763,000 | $-8,052,000 | $-5,821,000 | $-7,056,000 | $-6,485,000 |
| Exchange Rate Effect | -13,000 | -32,000 | 8,000 | 15,000 | -64,000 |
| Beginning Cash Position | 8,710,000 | 12,736,000 | 10,098,000 | 13,915,000 | 9,427,000 |
| End Cash Position | 7,441,000 | 8,710,000 | 12,736,000 | 10,098,000 | 13,915,000 |
| Net Cash Flow | $-1,256,000 | $-3,994,000 | $2,630,000 | $-3,832,000 | $4,552,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,081,000 | 10,258,000 | 10,526,000 | 10,522,000 | 7,449,000 |
| Capital Expenditure | -3,195,000 | -3,024,000 | -2,201,000 | -2,043,000 | -2,114,000 |
| Free Cash Flow | 5,886,000 | 7,234,000 | 8,325,000 | 8,479,000 | 5,335,000 |